Nexus Pharma Glutanex Glow Therapy Ampoule: Achieve Radiant Skin

Product Overview

The Glutanex Glow Therapy Ampoule is part of Nexus Pharma's topical glutathione product line, which extends the clinical profile of parenteral Glutanex formulations into non-invasive skincare applications. Glutathione (γ-L-glutamyl-L-cysteinyl-glycine) is a tripeptide antioxidant that occurs endogenously in human cells and is a well-characterised inhibitor of the melanogenesis pathway. Topical delivery of glutathione has been investigated in multiple randomised controlled trials as a skin-lightening and antioxidant strategy, including a 2014 double-blind RCT published in the British Journal of Dermatology (Watanabe et al.) demonstrating measurable melanin reduction following topical glutathione application. The Glutanex Glow Therapy Ampoule is formulated to enhance skin penetration of the active and is indicated for use as an adjunct to in-clinic aesthetic procedures or as a standalone brightening regimen in patients presenting with post-inflammatory hyperpigmentation, melasma, solar lentigines, and uneven skin tone.

In Singapore's aesthetic medicine and dermatology sector, glutathione-containing topicals are used as part of comprehensive skin brightening protocols, often alongside procedures such as chemical peels, laser toning (Q-switched Nd:YAG), and microneedling. EMIS Asia supplies the Glutanex Glow Therapy Ampoule to aesthetic clinics, dermatology practices, and professional skincare providers as part of its cosmeceutical and clinic consumables range. The product is manufactured in a Korean GMP-certified pharmaceutical facility under quality standards aligned with KFDA (Korean Ministry of Food and Drug Safety) cosmeceutical regulations.

Specifications

Clinical Applications

• Post-laser brightening maintenance: Applied following Q-switched Nd:YAG laser toning or IPL treatments to maintain and extend melanin-suppressive effects and reduce post-procedure oxidative stress at the dermal-epidermal junction.
• Melasma adjunct therapy: Used alongside topical hydroquinone, azelaic acid, or tranexamic acid in combination depigmentation protocols for patients with refractory melasma, providing an additional tyrosinase-inhibitory mechanism.
• Post-inflammatory hyperpigmentation (PIH) management: Indicated following inflammatory acne, contact dermatitis, or procedural wounds where excess melanin deposition impairs cosmetic outcome.
• Pre-event skin brightening protocol: Short-term intensive use as a professional-grade treatment ampoule for patients seeking rapid, visible skin luminosity improvement in the 2–4 week period prior to a significant event.
• Antioxidant skin maintenance: Ongoing application as part of an antioxidant-led skincare protocol for patients in high UV-exposure environments, supporting cellular glutathione replenishment and minimising photoageing-related pigmentation.

Frequently Asked Questions

Q: What is the clinical evidence for topical glutathione as a skin-brightening agent?
A: Multiple peer-reviewed studies support topical glutathione for skin lightening. A double-blind, randomised, placebo-controlled trial by Watanabe et al. (British Journal of Dermatology, 2014) demonstrated statistically significant reduction in melanin index following 4 weeks of topical glutathione application compared to placebo. A 2017 systematic review in the Journal of Clinical and Aesthetic Dermatology confirmed glutathione's role in inhibiting tyrosinase, the rate-limiting enzyme in melanogenesis, via both direct enzyme inhibition and suppression of DOPA quinone-mediated melanin polymerisation.

Q: How does the Glutanex Glow Therapy Ampoule differ from Glutanex injectable formulations?
A: The injectable Glutanex line (Glutanex IV, Glutanex Injection) contains lyophilised parenteral glutathione (600–1200 mg per ampoule) for intravenous or intramuscular administration in clinic settings under medical supervision. The Glow Therapy Ampoule is a topical cosmeceutical product designed for non-invasive self-application or professional use as part of an aesthetic facial protocol. Topical and injectable formulations have different bioavailability profiles and are used in distinct clinical contexts.

Q: Can this product be used alongside other active ingredients such as retinol or AHAs?
A: Glutathione is a stable antioxidant across a wide pH range and is generally compatible with niacinamide, vitamin C derivatives, peptides, and hyaluronic acid. Caution is advised when layering with high-concentration retinoids or AHAs at low pH, as this may increase skin sensitivity. Aesthetic clinicians managing complex protocols should sequence actives to maximise efficacy and minimise irritation, typically applying the Glutanex ampoule before thicker emollients and after water-based actives.

Q: Is this product suitable for purchase by Singapore aesthetic clinics without a prescription?
A: Yes. The Glutanex Glow Therapy Ampoule is a topical cosmeceutical product, not a pharmaceutical prescription item in Singapore. It is available through EMIS Asia for direct purchase by licensed aesthetic clinics, dermatology practices, medical spas, and professional skincare providers. Individual retail quantities are also available for end-consumer purchase.

Q: What is the recommended protocol for clinic use?
A: In aesthetic clinic settings, the ampoule may be used as a booster serum applied to cleansed skin following professional treatments such as laser, IPL, or microneedling, once the skin surface has been assessed as intact and barrier recovery is underway. Home-use protocols typically involve once-daily application to cleansed skin, followed by a broad-spectrum SPF 30+ sunscreen during daytime to prevent UV-induced re-pigmentation, which remains the primary driver of melanin recurrence in treated patients.